New drug given during breast cancer surgery shows early promise
Disease control
Completed
This early-phase trial tested a new drug called SRG-514 in 25 people undergoing breast-conserving surgery for breast cancer. The drug was given directly into the area where the tumor was removed. The main goal was to find a safe dose and check for side effects. This is a first st…
Phase: PHASE1 • Sponsor: SURGE Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC